Latest News

  • RESEARCH

    7 Nov 2025

    Nanoform and Takeda Bet on Miniature Science
  • INNOVATION

    5 Nov 2025

    The Next Big Breakthrough in Biologics Starts at Home
  • INVESTMENT

    3 Nov 2025

    Pill Power: Lexaria’s $4M Shot at Ending Injections
  • INNOVATION

    31 Oct 2025

    Biologics in Minutes: Halozyme Bets Big on Speed

The Tiny Tech Turning Biologics Into Simple Shots

The Tiny Tech Turning Biologics Into Simple Shots

TECHNOLOGY

29 Oct 2025

Acquisition of Electrofi adds next-gen drug formulation and smart injection technology to Halozyme’s tech portfolio

AI Cloud Labs Are Reshaping Drug Development Fast

TECHNOLOGY

31 May 2025

AI Cloud Labs Are Reshaping Drug Development Fast

Persist AI’s cloud lab speeds up drug R&D with AI and robotics, offering faster, cheaper formulation without traditional labs.

Drug Delivery Without a Cut? Caltech’s Ultrasound Fix

INNOVATION

15 May 2025

Drug Delivery Without a Cut? Caltech’s Ultrasound Fix

Ultrasound-triggered implants may reduce need for surgery and reshape future of targeted therapy

From mRNA to ADCs: PCI Bets Big on Biotech Boom

PARTNERSHIPS

9 May 2025

From mRNA to ADCs: PCI Bets Big on Biotech Boom

Pharma firm PCI buys Althea site to boost US production of next-gen injectables like ADCs and mRNA therapies.

Drug Purity Rules Get a Global Upgrade

REGULATORY

2 May 2025

Drug Purity Rules Get a Global Upgrade

USP’s 2026 standards push pharma to modernize impurity testing

Rewiring Cancer Drugs for Sharper Aim

INSIGHTS

30 Apr 2025

Rewiring Cancer Drugs for Sharper Aim

Synthetic Design Lab launches SYNTHBODY to improve drug targeting for aggressive, treatment-resistant cancers

Keytruda in a Flash: Merck’s 2-Minute Cancer Shot

PARTNERSHIPS

11 Apr 2025

Keytruda in a Flash: Merck’s 2-Minute Cancer Shot

A Merck-Alteogen breakthrough could slash cancer treatment time to two minutes

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.